Alya Khan McGinlay

Title: Alya Khan McGinlay: Innovator in Gamma-Hydroxybutyrate Formulations

Introduction

Alya Khan McGinlay is a notable inventor based in Belmont, California. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of immediate release dosage forms for gamma-hydroxybutyrate (GHB). Her innovative work has the potential to enhance the bioavailability of GHB, making it more effective for oral administration.

Latest Patents

Alya holds a patent for "Immediate release formulations and dosage forms of gamma-hydroxybutyrate." This invention provides a solid immediate release dosage form adapted for oral administration of GHB. The formulation includes a relatively high weight-percentage of GHB, achieving a bioavailability similar to that of a liquid GHB dosage form. This advancement is crucial for improving patient compliance and therapeutic outcomes.

Career Highlights

Alya is currently employed at Jazz Pharmaceuticals, Inc., where she continues to work on innovative pharmaceutical solutions. Her expertise in drug formulation and development has positioned her as a valuable asset in the industry. With her dedication to research and development, she is paving the way for new therapeutic options.

Collaborations

Alya collaborates with talented professionals in her field, including Andrea Marie Rourke and Maura Patricia Murphy. These partnerships enhance her research efforts and contribute to the success of her projects.

Conclusion

Alya Khan McGinlay is a pioneering inventor whose work in gamma-hydroxybutyrate formulations is making a significant impact in the pharmaceutical industry. Her innovative approach and dedication to improving drug delivery systems are commendable.